Olanzapine
- Product NDC
- 67046-522
- 11-digit product format
- 670460522
- Labeler code
- 67046
- Product ID
- 67046-522_5a1dc228-b758-5f2b-e053-2991aa0adccc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olanzapine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Contract Pharmacy Services-PA
- Application
- ANDA090798
- Marketing category
- ANDA
- Marketing start
- 2017-09-26
- Marketing end
- 0000-00-00
- Substance
- OLANZAPINE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 67046-522-07 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e3fe-f424-e053-dadaa90a57ce | 522 Olanzapine 5 mg 523 Olanzapine 15 mg These highlights do not include all the information needed to use OLANZAPINE TABLETS safely and effectively. See full prescribing information for OLANZAPINE TABLETS. OLANZAPINE tablets, for oral use Initial U.S. Approval: 1996 |
| 67046-522-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e3fe-f424-e053-dadaa90a57ce | 522 Olanzapine 5 mg 523 Olanzapine 15 mg These highlights do not include all the information needed to use OLANZAPINE TABLETS safely and effectively. See full prescribing information for OLANZAPINE TABLETS. OLANZAPINE tablets, for oral use Initial U.S. Approval: 1996 |
| 67046-522-15 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e3fe-f424-e053-dadaa90a57ce | 522 Olanzapine 5 mg 523 Olanzapine 15 mg These highlights do not include all the information needed to use OLANZAPINE TABLETS safely and effectively. See full prescribing information for OLANZAPINE TABLETS. OLANZAPINE tablets, for oral use Initial U.S. Approval: 1996 |
| 67046-522-20 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e3fe-f424-e053-dadaa90a57ce | 522 Olanzapine 5 mg 523 Olanzapine 15 mg These highlights do not include all the information needed to use OLANZAPINE TABLETS safely and effectively. See full prescribing information for OLANZAPINE TABLETS. OLANZAPINE tablets, for oral use Initial U.S. Approval: 1996 |
| 67046-522-21 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e3fe-f424-e053-dadaa90a57ce | 522 Olanzapine 5 mg 523 Olanzapine 15 mg These highlights do not include all the information needed to use OLANZAPINE TABLETS safely and effectively. See full prescribing information for OLANZAPINE TABLETS. OLANZAPINE tablets, for oral use Initial U.S. Approval: 1996 |
| 67046-522-28 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e3fe-f424-e053-dadaa90a57ce | 522 Olanzapine 5 mg 523 Olanzapine 15 mg These highlights do not include all the information needed to use OLANZAPINE TABLETS safely and effectively. See full prescribing information for OLANZAPINE TABLETS. OLANZAPINE tablets, for oral use Initial U.S. Approval: 1996 |
| 67046-522-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e3fe-f424-e053-dadaa90a57ce | 522 Olanzapine 5 mg 523 Olanzapine 15 mg These highlights do not include all the information needed to use OLANZAPINE TABLETS safely and effectively. See full prescribing information for OLANZAPINE TABLETS. OLANZAPINE tablets, for oral use Initial U.S. Approval: 1996 |
| 67046-522-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e3fe-f424-e053-dadaa90a57ce | 522 Olanzapine 5 mg 523 Olanzapine 15 mg These highlights do not include all the information needed to use OLANZAPINE TABLETS safely and effectively. See full prescribing information for OLANZAPINE TABLETS. OLANZAPINE tablets, for oral use Initial U.S. Approval: 1996 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67046-522-07 | Olanzapine | 7 in 1 BLISTER PACK | TABLET, FILM COATED | 7 | | 1 |
| 67046-522-14 | Olanzapine | 14 in 1 BLISTER PACK | TABLET, FILM COATED | 14 | | 1 |
| 67046-522-15 | Olanzapine | 15 in 1 BLISTER PACK | TABLET, FILM COATED | 15 | | 1 |
| 67046-522-20 | Olanzapine | 20 in 1 BLISTER PACK | TABLET, FILM COATED | 20 | | 1 |
| 67046-522-21 | Olanzapine | 21 in 1 BLISTER PACK | TABLET, FILM COATED | 21 | | 1 |
| 67046-522-28 | Olanzapine | 28 in 1 BLISTER PACK | TABLET, FILM COATED | 28 | | 1 |
| 67046-522-30 | Olanzapine | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | | 1 |
| 67046-522-60 | Olanzapine | 60 in 1 BLISTER PACK | TABLET, FILM COATED | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67046-522 | OLANZAPINE TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] | 1 | Legacy NDC, 8 package rows | 20170927_5a1dc228-b757-5f2b-e053-2991aa0adccc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 67046-522-07 | 67046052207 | 7 in 1 BLISTER PACK | Historical |
| 67046-522-14 | 67046052214 | 14 in 1 BLISTER PACK | Historical |
| 67046-522-15 | 67046052215 | 15 in 1 BLISTER PACK | Historical |
| 67046-522-20 | 67046052220 | 20 in 1 BLISTER PACK | Historical |
| 67046-522-21 | 67046052221 | 21 in 1 BLISTER PACK | Historical |
| 67046-522-28 | 67046052228 | 28 in 1 BLISTER PACK | Historical |
| 67046-522-30 | 67046052230 | 30 in 1 BLISTER PACK | Historical |
| 67046-522-60 | 67046052260 | 60 in 1 BLISTER PACK | Historical |